Drupal.behaviors.print = function(context) {window.print();window.close();}>
Rosetta Genomics Launches Lung Cancer Diagnostic
July 14, 2011
Rosetta Genomics Launches Lung Cancer Diagnostic
The test will be commercialized in the US by the company's recently formed sales team.
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Rosetta Publishes Data on microRNA-Based Lung Cancer Assay
July 5, 2012 / Gene Silencing News
Rosetta Settles Dispute over Lab Sale
April 18, 2013 / Gene Silencing News
Rosetta Genomics' 2012 Revenues Nearly Double
March 25, 2013 / GenomeWeb Daily News
Rosetta Genomics Opposes Monsanto Acquisition of Former Subsidiary
March 7, 2013 / Gene Silencing News
Chemoprevention Study Identifies miRNA-34c as Potential Surrogate Endpoint for Future Trials
January 17, 2013 / Gene Silencing News